TTEK - Jim Cramer: This Healthcare Stock Is 'Too Risky' But Shares Jumped 64% Over Past Month | Benzinga
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is "too risky."
Praxis Precision Medicines recently priced its underwritten public offering of 3.17 million shares at $35.50 per share and, in lieu of shares of common stock, pre-funded warrants to purchase up to 1.06 million shares at $35.4999 per pre-funded warrant, for gross proceeds of $150 million. The Boston-based company’s shares jumped around 64% over the past month.
Cramer said no to U.S. Silica ...